Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Watkins

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
American Journal of Clinical Oncology|December 10, 1997
Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazoleC A Jamis-Dow, M L Pearl, P B Watkins, et al.
Clinical Pharmacology and Therapeutics|June 29, 2000
Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adultsK E Thummel, J T Slattery, H Ro, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1985
Identification of an inducible form of cytochrome P-450 in human liverP B Watkins, S A Wrighton, P Maurel, et al.
Molecular Pharmacology|July 1, 1996
Bimodal distribution of renal cytochrome P450 3A activity in humansB D Haehner, J C Gorski, M Vandenbranden, et al.
Clinical Pharmacology and Therapeutics|January 1, 1995
The erythromycin breath test predicts the clearance of midazolamK S Lown, K E Thummel, P E Benedict, et al.
Clinical Pharmacology and Therapeutics|September 1, 1994
P450 3A activity and cyclosporine dosing in kidney and heart transplant recipientsD K Turgeon, A B Leichtman, K S Lown, et al.
Transplantation|June 27, 1994
Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipientsD K Turgeon, A B Leichtman, D S Blake, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994
Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath testK S Lown, J C Kolars, K E Thummel, et al.
Clinical Pharmacology and Therapeutics|January 11, 1992
Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisolC M Hunt, P B Watkins, P Saenger, et al.
Pharmacogenetics|October 1, 1994
CYP3A gene expression in human gut epitheliumJ C Kolars, K S Lown, P Schmiedlin-Ren, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Oncology|December 10, 1997
Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazoleC A Jamis-Dow, M L Pearl, P B Watkins, et al.
Clinical Pharmacology and Therapeutics|June 29, 2000
Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adultsK E Thummel, J T Slattery, H Ro, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1985
Identification of an inducible form of cytochrome P-450 in human liverP B Watkins, S A Wrighton, P Maurel, et al.
Molecular Pharmacology|July 1, 1996
Bimodal distribution of renal cytochrome P450 3A activity in humansB D Haehner, J C Gorski, M Vandenbranden, et al.
Clinical Pharmacology and Therapeutics|January 1, 1995
The erythromycin breath test predicts the clearance of midazolamK S Lown, K E Thummel, P E Benedict, et al.
Clinical Pharmacology and Therapeutics|September 1, 1994
P450 3A activity and cyclosporine dosing in kidney and heart transplant recipientsD K Turgeon, A B Leichtman, K S Lown, et al.
Transplantation|June 27, 1994
Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipientsD K Turgeon, A B Leichtman, D S Blake, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994
Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath testK S Lown, J C Kolars, K E Thummel, et al.
Clinical Pharmacology and Therapeutics|January 11, 1992
Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisolC M Hunt, P B Watkins, P Saenger, et al.
Pharmacogenetics|October 1, 1994
CYP3A gene expression in human gut epitheliumJ C Kolars, K S Lown, P Schmiedlin-Ren, et al.
Pageof 10